Gita Ramjee received her Ph.D. degree at the University of Natal, South Africa, in 1994 and was awarded a distinguished visiting professorship by the Tamil Nadu Medical University in India. Ramjee was recently a finalist in the Woman of the Year awards in South Africa. She heads the South Africa Medical Research Council’s HIV Prevention Research Unit. She has been the principal investigator of a number of microbicides trials including the Population Council’s Phase 3 Carraguard clinical trial. She has been a member of several committees, including the Cochair of the Microbicides Development Programme’s Management Committee, and a Member of the International Committee for Contraception Research, the International Working Group on Microbicides, the Microbicide Trials Network Executive Committee, and several steering committees. Ramjee has been a cochair on three microbicides conferences (2006, 2008, and 2010). Her research interests focus on HIV prevention and women-initiated prevention options such as microbicides and vaccines as well as treatment and care of HIV-positive populations. Ramjee has been instrumental in addressing the needs of HIV-positive women screened out of clinical trials and those who seroconvert during the course of the trials. She has pioneered a care program in partnership with health service providers and PEPFAR to ensure continuum of care for HIV-positive women, including ARV therapy.
Biography Updated on 3 January 2012